# SLC38A9

## Overview
SLC38A9 is a gene that encodes the protein solute carrier family 38 member 9, a lysosomal transmembrane protein involved in amino acid transport and cellular signaling. The protein functions as a transceptor, integrating the roles of both a transporter and a receptor, and is pivotal in the regulation of the mechanistic target of rapamycin complex 1 (mTORC1) signaling pathway, which is essential for cell growth and metabolism. SLC38A9 facilitates the transport of amino acids, particularly glutamine and arginine, across the lysosomal membrane and acts as a guanine exchange factor for Rag GTPases, thereby influencing mTORC1 activation in response to nutrient availability (Shen2018Ragulator; Scalise2019Insights). The protein's activity is modulated by cholesterol and amino acids, and it interacts with components of the mTORC1 signaling pathway, including the Rag-Ragulator complex and Niemann-Pick C1 (NPC1) protein, highlighting its role in cholesterol sensing and transport (Castellano2017Lysosomal).

## Structure
The SLC38A9 protein is a lysosomal amino acid transporter characterized by its complex molecular structure. It features 11 transmembrane alpha helices that form a transmembrane bundle, which is crucial for its function in amino acid transport (Jinming2018A). The protein's N-terminal domain plays a significant role in its function, undergoing a conformational change that is essential for mTORC1 activation. In the absence of arginine, this domain forms a beta hairpin that blocks the transport path by inserting into the transporter (Jinming2018A).

The N-terminal tail of SLC38A9, consisting of 119 amino acids, is cytoplasm-facing and mediates interactions with the Rag-Ragulator complex, which is important for mTORC1 regulation (Jung2015Amino). This domain is also involved in the protein's interaction with the Rag GTPase complex, acting as a guanine exchange factor (GEF) for RAGA in the presence of amino acids (Scalise2019Insights).

The protein's structure includes specific residues responsible for arginine binding, and it has been shown to have a sodium-dependent transport mechanism, with a novel Na+ binding site identified at residue T453 (Scalise2019Insights). The presence of cholesterol in the lysosomal membrane positively regulates its receptor function (Scalise2019Insights).

## Function
SLC38A9 is a lysosomal amino acid transporter that plays a crucial role in the regulation of the mechanistic target of rapamycin complex 1 (mTORC1) signaling pathway, which is essential for cell growth and metabolism. It functions as a transceptor, combining the roles of a transporter and a receptor, and is involved in the transport of amino acids, particularly glutamine and arginine, across the lysosomal membrane (Scalise2019Insights). 

SLC38A9 is activated by cholesterol and amino acids, and it interacts with the mTORC1 complex through its N-terminus, which is crucial for its receptor function but not for its transport activity (Castellano2017Lysosomal; Scalise2019Insights). The protein is part of a signaling complex with Niemann-Pick C1 (NPC1), which regulates cholesterol export from the lysosome and influences mTORC1 activation (Castellano2017Lysosomal). 

SLC38A9 also acts as a guanine exchange factor (GEF) for Rag GTPases, facilitating the activation of mTORC1 in response to nutrient availability, particularly arginine (Shen2018Ragulator). This dual function in amino acid transport and mTORC1 activation is vital for regulating key cellular functions such as metabolism, growth, and proliferation (Scalise2019Insights).

## Clinical Significance
Mutations and alterations in the SLC38A9 gene have been linked to various health conditions, primarily through their impact on the mTORC1 signaling pathway. A specific variant, rs4865615-C, in the SLC38A9 gene is associated with a decreased risk of chronic kidney disease. This variant is a missense mutation (p.Ser182Thr) that may influence the function of SLC38A9 and subsequently affect mTORC1 activity, which is crucial for renal cell homeostasis (Crocco2022The).

The SLC38A9 gene is also implicated in the development of type 2 diabetes (T2D) and its complications. Although no significant association was found between SLC38A9 SNPs and T2D at a nominal threshold, genetic variability in this gene may contribute to the disease by affecting mTORC1 activity in metabolic organs such as the pancreas, liver, and skeletal muscle (Crocco2022The).

Additionally, SLC38A9 plays a role in cholesterol-mediated mTORC1 activation. Its interaction with the Niemann-Pick C1 (NPC1) protein is crucial for mTORC1 regulation, and disruptions in this interaction can affect cellular metabolism and growth, potentially contributing to metabolic disorders (Castellano2017Lysosomal).

## Interactions
SLC38A9 is a lysosomal transmembrane protein that interacts with several components of the mTORC1 signaling pathway. It is a part of the Rag-Ragulator complex, which is essential for mTORC1 activation in response to amino acid availability. SLC38A9 interacts with Rag GTPases, including RRAGA, RRAGB, and RRAGC, as well as with Ragulator subunits such as LAMTOR1, LAMTOR3, and LAMTOR4 (Jung2015Amino). These interactions are sensitive to amino acid levels, with enhanced binding observed under amino acid starvation conditions (Jung2015Amino).

The N-terminal domain of SLC38A9 is crucial for its interaction with the Rag-Ragulator complex, and this domain can mediate mTORC1 activation by interacting with the Rag GTPase complex (Jinming2018A). SLC38A9 also interacts with cholesterol, which influences mTORC1 activation. It contains a cholesterol recognition amino acid consensus (CRAC) motif, which is involved in cholesterol-mediated signaling (Castellano2017Lysosomal). The protein's interaction with NPC1, a cholesterol transporter, suggests a role in cholesterol sensing and transport, further impacting mTORC1 regulation (Castellano2017Lysosomal). These interactions highlight SLC38A9's role as a critical component in the regulation of mTORC1 activity through amino acid and cholesterol sensing.


## References


[1. (Shen2018Ragulator) Kuang Shen and David M. Sabatini. Ragulator and slc38a9 activate the rag gtpases through noncanonical gef mechanisms. Proceedings of the National Academy of Sciences, 115(38):9545–9550, September 2018. URL: http://dx.doi.org/10.1073/pnas.1811727115, doi:10.1073/pnas.1811727115. This article has 147 citations.](https://doi.org/10.1073/pnas.1811727115)

2. (Jinming2018A) A conformational change in the N terminus of SLC38A9 signals mTORC1 activation. This article has 1 citations.

[3. (Crocco2022The) Paolina Crocco, Serena Dato, Alberto Montesanto, Anna Rita Bonfigli, Roberto Testa, Fabiola Olivieri, Giuseppe Passarino, and Giuseppina Rose. The genetic variability of members of the slc38 family of amino acid transporters (slc38a3, slc38a7 and slc38a9) affects susceptibility to type 2 diabetes and vascular complications. Nutrients, 14(21):4440, October 2022. URL: http://dx.doi.org/10.3390/nu14214440, doi:10.3390/nu14214440. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/nu14214440)

[4. (Castellano2017Lysosomal) Brian M. Castellano, Ashley M. Thelen, Ofer Moldavski, McKenna Feltes, Reini E. N. van der Welle, Laurel Mydock-McGrane, Xuntian Jiang, Robert J van Eijkeren, Oliver B. Davis, Sharon M. Louie, Rushika M. Perera, Douglas F. Covey, Daniel K. Nomura, Daniel S. Ory, and Roberto Zoncu. Lysosomal cholesterol activates mtorc1 via an slc38a9–niemann-pick c1 signaling complex. Science, 355(6331):1306–1311, March 2017. URL: http://dx.doi.org/10.1126/science.aag1417, doi:10.1126/science.aag1417. This article has 403 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/science.aag1417)

[5. (Jung2015Amino) Jennifer Jung, Heide Marika Genau, and Christian Behrends. Amino acid-dependent mtorc1 regulation by the lysosomal membrane protein slc38a9. Molecular and Cellular Biology, 35(14):2479–2494, July 2015. URL: http://dx.doi.org/10.1128/mcb.00125-15, doi:10.1128/mcb.00125-15. This article has 278 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.00125-15)

[6. (Scalise2019Insights) Mariafrancesca Scalise, Michele Galluccio, Lorena Pochini, Jessica Cosco, Miriam Trotta, Manuele Rebsamen, Giulio Superti-Furga, and Cesare Indiveri. Insights into the transport side of the human slc38a9 transceptor. Biochimica et Biophysica Acta (BBA) - Biomembranes, 1861(9):1558–1567, September 2019. URL: http://dx.doi.org/10.1016/j.bbamem.2019.07.006, doi:10.1016/j.bbamem.2019.07.006. This article has 26 citations.](https://doi.org/10.1016/j.bbamem.2019.07.006)